Loading candles…
Gujarat Themis Biosyn Ltd, incorporated in 1981, operates in the pharmaceutical industry, focusing on the manufacture and sale of finished Active Pharmaceutical Ingredients (APIs) using fermentation technology. The company produces APIs and intermediates through fermentation processes and primarily serves formulation manufacturers within the domestic market. Its notable activities include supplying critical raw materials for anti-tuberculosis and other therapeutic segments, expanding its fermentation capacities, and acquiring global brand portfolios to transition from a regional manufacturer to a global pharmaceutical player. No information is provided regarding its headquarters, founders, key management, subsidiaries, or stock exchange listings.
| Date |
|---|
| Fund Raising | To consider Fund Raising | 19 Jun 2026 |
| Fund Raising | Gujarat Themis Biosyn Limited has informed the Exchange that the meeting of the Board of Directors of the Company scheduled to be held on Jun 19, 2026 To con… | 19 Jun 2026 |
| Fund Raising | To consider Fund Raising and other business matters | 6 Jun 2026 |
| Results - FY26 | To consider and approve the financial results for the period ended March 31, 2026, Recommending Dividend, If any, for the Financial year ended 31.03.2026; Co… | 25 May 2026 |
| Fund Raising | To consider Fund Raising | 25 May 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 | 5 Feb 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended September 30, 2025 | 10 Nov 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended Jun 30, 2025 | 1 Aug 2025 |
Besseggen InfoTech LLP is a SEBI-registered stock broker (Reg. No. INZ000213450), member of NSE (90155 (Cash & F&O)) and BSE (6722 (Cash & F&O)). Investment in securities market are subject to market risks; read all related documents carefully before investing.